Dalrada Financl Stock Price, News & Analysis
Company Description
Dalrada Financial Corporation (DFCO), now known as Dalrada Technology Group, Inc., is a multi-national holding company that develops, manufactures, and sells products and services across the clean energy, semiconductor deposition technology, precision manufacturing, and health care sectors. According to multiple company press releases, Dalrada operates through core segments that include Dalrada Climate Technology, Deposition Technology (Deptec), and Genefic Specialty Pharmacy.
Business Model and Core Segments
Dalrada’s business model centers on owning and operating specialized subsidiaries in high-technology and health-related markets. The company describes itself as a multi-national holding company whose subsidiaries focus on clean energy solutions, advanced thin-film deposition and semiconductor technologies, and specialty pharmacy services.
Dalrada Climate Technology focuses on heat pump and energy sustainability technology. Company disclosures state that this segment offers heat pump technology for industrial and residential applications and is involved in climate technology that supports energy efficiency and emissions reduction for light commercial and industrial facilities.
Deposition Technology (Deptec) is described as an international leader in deposition technology and precision manufacturing. It specializes in thin-film deposition, including Physical Vapor Deposition (PVD) and Chemical Vapor Deposition (CVD) processing and equipment. Deptec’s activities include upgrading legacy deposition tools and providing systems and tools for semiconductor manufacturing, microelectronics, MEMS, optoelectronics, and advanced material processing. Dalrada’s news also highlights Deptec’s proprietary plasma spectrometer, Spectroptix®, designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes.
Genefic Specialty Pharmacy, a wholly-owned subsidiary under the Genefic, Inc. umbrella, operates in the health care sector. Company materials describe Genefic as delivering frontline health products and services through redesigned systems and reimagined patient care. Genefic Specialty Pharmacy provides end-to-end prescription and specialty pharmacy services, patient advocacy and support, and medical education, and operates licensed diagnostic laboratories and a specialty pharmacy platform.
Clean Energy and Climate Technology Focus
Dalrada’s clean energy activities are centered on its climate technology segment. Press releases describe Dalrada heat pumps as energy efficient and suited for light commercial and industrial applications. The company has announced contracts for the purchase and installation of its heat pumps in European facilities and a master distribution agreement in the United States that targets sales of commercial and residential heat pump units across multiple regions.
The company also notes that its flagship DCT One Series CO₂ heat pumps are supported by a U.S.-based testing and production facility, with research and development activities for additional heat pump systems referenced in its climate technology communications. These efforts are positioned by Dalrada as part of a broader push toward sustainable building solutions and reduced carbon footprints.
Deposition Technology and Semiconductor-Related Operations
Through Deposition Technology Inc. (Deptec), Dalrada is active in advanced thin-film deposition and semiconductor-related equipment. Company news describes Deptec as specializing in PVD and CVD systems and upgrades for legacy deposition tools, including Novellus Concept One systems, with the goal of enhancing performance, reliability, and cost efficiency in manufacturing processes.
Dalrada has highlighted Deptec’s Spectroptix® plasma spectrometer, which is designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes. According to Dalrada’s descriptions, Spectroptix® provides real-time data on materials within each vacuum chamber, supports process control, and can be integrated into various vacuum-based processes, including thin film coatings and plasma-enhanced CVD and PVD systems.
The company has also announced the establishment of a manufacturing and research and development facility in Portland, Oregon, for Deposition Technology USA, Inc. This facility is described as a U.S. headquarters for Deptec, intended to accelerate production and sales of deposition technology products to support North American and global markets, and to serve as a U.S.-based testing and production site for Dalrada’s climate technology products.
Health Care and Specialty Pharmacy
In health care, Dalrada operates through Genefic, Inc. and Genefic Specialty Pharmacy. Company information states that Genefic delivers health products and services through redesigned systems and reimagined patient care. Genefic Specialty Pharmacy is described as offering end-to-end prescription services, specialty pharmacy services, patient advocacy and support, and medical education.
Dalrada’s communications further indicate that Genefic has licensed diagnostic laboratories, a 50-state licensed specialty pharmacy, and an infusion pharmacy. The company highlights Genefic’s focus on multiple pharmaceutical sectors and an approach aimed at covering multiple verticals within the pharmacy market.
Corporate Evolution and Name Change
Dalrada Financial Corporation has reported that it changed its name and trading symbol to Dalrada Technology Group, Inc., with the new ticker symbol "DHTI" on the OTC Markets. A press release states that the company is headquartered in Escondido, California, and describes Dalrada Technology Group, Inc. as a multi-national holding company dedicated to innovation in technology, health care, and environmental sustainability.
The company has stated that the change in trading symbol does not affect its share structure, operations, or financial reporting requirements, and that shareholders are not required to take any action as a result of this change. The historical DFCO symbol is therefore associated with Dalrada Financial Corporation prior to the reported name and symbol change.
Geographic and Operational Footprint
Dalrada’s public communications reference operations and presence in multiple locations. The company has described itself as having a global footprint in clean energy solutions, advanced technology, and sustainable manufacturing. It has referenced operations and activities in the United States and Europe, including a manufacturing and R&D facility in Portland, Oregon, and climate technology projects and partnerships in France and Spain.
Company materials also refer to an existing presence in several U.S. states and multiple international regions through its subsidiaries and business relationships, particularly in relation to its climate technology and health care operations.
Governance, Reporting, and Regulatory Filings
Dalrada files reports with the U.S. Securities and Exchange Commission (SEC). An 8-K filing dated October 31, 2025, notes that the company, identified as Dalrada Technology Group, Inc. (formerly Dalrada Financial Corporation), reported the resignation of its Chief Financial Officer and indicated that the resignation was not due to any disagreement regarding accounting practices, financial statements, or disclosures. The filing also states that the company is in the process of identifying and appointing a successor.
Other company announcements discuss the engagement and selection of independent registered public accounting firms to audit Dalrada’s consolidated financial statements and support its reporting obligations, reflecting the company’s status as a reporting issuer.
Subsidiaries and Segment Relationships
Dalrada’s structure, as described in its press releases, includes wholly-owned subsidiaries and distinct business segments:
- Dalrada Climate Technology – climate and heat pump technology for industrial and residential applications.
- Deposition Technology (Deptec) – thin-film deposition and semiconductor-related equipment and services, including PVD and CVD systems and upgrades.
- Genefic, Inc. / Genefic Specialty Pharmacy – health care and specialty pharmacy services, including prescription services, diagnostic laboratories, and patient support.
These segments are presented by the company as its core operating areas, each contributing to its overall focus on clean energy, advanced technology, and health care.
Historical Context for DFCO Ticker
The DFCO ticker historically represented Dalrada Financial Corporation, a multi-national holding company with activities in clean energy, deposition technology for semiconductors, precision manufacturing, and health care. Company disclosures indicate that the corporate entity later reported a name and symbol change to Dalrada Technology Group, Inc. trading under "DHTI" on the OTC Markets. For investors and researchers, DFCO therefore serves as a historical symbol associated with Dalrada’s earlier corporate identity and disclosures.
Stock Performance
Dalrada Financl (DFCO) stock last traded at $0.0350. Over the past 12 months, the stock has lost 31.2%. At a market capitalization of $7.8M, DFCO is classified as a micro-cap stock with approximately 120.2M shares outstanding.
Latest News
Dalrada Financl has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include management. View all DFCO news →
SEC Filings
Dalrada Financl has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-Q, 1 Form NT 10-Q, 1 Form 8-K/A. The most recent filing was submitted on February 21, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DFCO SEC filings →
Financial Highlights
Dalrada Financl generated $20.3M in revenue over the trailing twelve months, retaining a 26.1% gross margin, operating income reached -$20.5M (-100.8% operating margin), and net income was -$24.6M, reflecting a -121.4% net profit margin. Diluted earnings per share stood at $-0.23. The company generated -$18.0M in operating cash flow. With a current ratio of 0.49, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Dalrada Financl (DFCO) currently stands at 20 shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 68.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Dalrada Financl (DFCO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
DFCO Company Profile & Sector Positioning
Dalrada Financl (DFCO) operates in the Consulting Services industry within the broader Industrials sector and is listed on the OTC Link.
Investors comparing DFCO often look at related companies in the same sector, including Crown Equity Hol (CRWE), American Diversified (ADHC), Golden Triangle Ventures Inc (GTVH), Blue Diamond (BLDV), and One World Univer (OWUV). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DFCO's relative position within its industry.